M&T Bank Corp Has $2.79 Million Holdings in Mirion Technologies, Inc. (NYSE:MIR)

M&T Bank Corp lessened its position in Mirion Technologies, Inc. (NYSE:MIR) by 20.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 160,116 shares of the company’s stock after selling 40,112 shares during the period. M&T Bank Corp’s holdings in Mirion Technologies were worth $2,794,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. KBC Group NV grew its stake in Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company’s stock valued at $140,000 after acquiring an additional 2,254 shares during the period. Oppenheimer & Co. Inc. grew its stake in Mirion Technologies by 4.7% in the third quarter. Oppenheimer & Co. Inc. now owns 58,260 shares of the company’s stock valued at $645,000 after acquiring an additional 2,595 shares during the period. Royce & Associates LP grew its stake in Mirion Technologies by 0.8% in the third quarter. Royce & Associates LP now owns 484,000 shares of the company’s stock valued at $5,358,000 after acquiring an additional 4,000 shares during the period. State of New Jersey Common Pension Fund D boosted its position in shares of Mirion Technologies by 2.3% during the third quarter. State of New Jersey Common Pension Fund D now owns 179,998 shares of the company’s stock valued at $1,993,000 after buying an additional 4,043 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its position in shares of Mirion Technologies by 10.5% during the fourth quarter. Handelsbanken Fonder AB now owns 61,031 shares of the company’s stock valued at $1,065,000 after buying an additional 5,800 shares during the last quarter. Institutional investors and hedge funds own 78.51% of the company’s stock.

Wall Street Analysts Forecast Growth

MIR has been the topic of several analyst reports. Citigroup lifted their target price on Mirion Technologies from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, December 4th. Baird R W raised Mirion Technologies to a “strong-buy” rating in a research report on Thursday, December 19th. The Goldman Sachs Group lifted their target price on Mirion Technologies from $16.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Finally, Robert W. Baird initiated coverage on Mirion Technologies in a research report on Thursday, December 19th. They set an “outperform” rating and a $22.00 target price on the stock. Three equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Mirion Technologies currently has a consensus rating of “Buy” and an average price target of $19.25.

Mirion Technologies Stock Performance

Shares of Mirion Technologies stock opened at $14.15 on Friday. The business’s fifty day simple moving average is $16.18 and its 200 day simple moving average is $14.70. The firm has a market capitalization of $3.29 billion, a P/E ratio of -74.49 and a beta of 0.74. Mirion Technologies, Inc. has a 12 month low of $9.11 and a 12 month high of $18.81. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, February 11th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. As a group, analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.